2020 High quality Dehydroepiandrosterone - Top Quality Peptide Powder 83150-76-9 Octreotide acetate For Tumour Treatment – Yibai
2020 High quality Dehydroepiandrosterone - Top Quality Peptide Powder 83150-76-9 Octreotide acetate For Tumour Treatment – Yibai Detail:
Product name |
Octreotide acetate |
Sequence |
[R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide |
MOQ |
1G |
CAS No. |
83150-76-9 |
Appearance |
white powder |
Molecular Formula |
C49H66N10O10S2.2(C2H4O2) |
Molecular Weight |
1139.35 |
Assay |
99% |
Application |
Pharma grade for research purpose |
Packing |
As per your request |
Storage |
Preserve in tight,light-resistant containers in a cool place |
Remarks |
NA |
Custom synthesis |
Available |
Supply Ability |
1kg/month |
Company Information
√ Management layer’s full experience in factory and skilled technicians followers; √ Quality is always our top consideration, Strict QC system; √ 11 years experienced exporting sales team; √ Independent R&D lab; √ Two signed long term GMP workshops; √ Rich resources of plenty idle factories for customized project; √ High Efficiency working team with consistent path.Product detail pictures:
Related Product Guide:
We provide good power in high-quality and progress,merchandising,revenue and internet marketing and operation for 2020 High quality Dehydroepiandrosterone - Top Quality Peptide Powder 83150-76-9 Octreotide acetate For Tumour Treatment – Yibai , The product will supply to all over the world, such as: Adelaide, Jeddah, Colombia, We have sufficient experience in producing products according to samples or drawings. We warmly welcome customers from home and abroad to visit our company, and to cooperate with us for a splendid future together.
By Carol from Bulgaria - 2017.06.29 18:55
The customer service staff's attitude is very sincere and the reply is timely and very detailed, this is very helpful for our deal,thank you.
By Judy from Afghanistan - 2017.06.29 18:55
Write your message here and send it to us